Glaucoma Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Points Status
24 avr. 2024 08h38 HE
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Glaucoma - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report,...
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
23 avr. 2024 13h42 HE
|
Novartis Pharma AG
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic...
Lennox-Gastaut Syndrome Global Clinical Trials Review 2024: Phase, Trial Status, End Points Status and Sponsor Type
23 avr. 2024 10h42 HE
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
17 avr. 2024 08h00 HE
|
Science 37, Inc.
Science 37's Patient Recruitment Solution provides fully-consented patients to clinical trial sites to supplement enrollment.
Cutaneous Squamous Cell Carcinoma (CSCC) Global Clinical Trials Review 2024: Trial Status, Trial Phase, Sponsor Type, End Point Status, Country (G7 & E7)
08 avr. 2024 09h31 HE
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma (Cscc) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
08 avr. 2024 09h20 HE
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report...
Seasonal Influenza Global Clinical Trials Review 2024 Featuring GSK, Novartis, Johnson & Johnson, Novavax, CSL, Sinovac Biotech, Moderna, and Sanofi, Among Others
05 avr. 2024 09h29 HE
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Seasonal Influenza - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities
04 avr. 2024 12h00 HE
|
H1
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- H1, the leading platform for global healthcare data with a database of 10M+ healthcare professional profiles, today announced a new module within its H1...
Glioblastoma Multiforme (GBM) Global Clinical Trials Review 2024, by Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
03 avr. 2024 11h27 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...
Lupus Nephritis Global Clinical Trials Review 2024
03 avr. 2024 11h13 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Lupus Nephritis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...